DiNuzzo Private Wealth’s Edwards Lifesciences EW Stock Holding History

DiNuzzo Private Wealth’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.71K	Hold	41	–	–	﹤0.01%	487
2026 Q1	$3.28K	Hold	41	–	–	﹤0.01%	486
2025 Q4	$3.5K	Sell	41 -1	-2%	-$82	﹤0.01%	455
2025 Q3	$3.42K	Buy	42 +2	+5%	+$156	﹤0.01%	466
2025 Q2	$3.13K	Buy	40 +4	+11%	+$298	﹤0.01%	475
2025 Q1	$2.61K	Hold	36	–	–	﹤0.01%	512
2024 Q4	$2.67K	Buy	36 +10	+38%	+$700	﹤0.01%	499
2024 Q3	$1.72K	Buy	26 +1	+4%	+$73	﹤0.01%	666
2024 Q2	$2.31K	Buy	25 +6	+32%	+$531	﹤0.01%	470
2024 Q1	$1.82K	Buy	19 +1	+6%	+$84	﹤0.01%	504
2023 Q4	$1.37K	Buy	+18	New	+$1.25K	﹤0.01%	578

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

TIM

Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return

DiNuzzo Private Wealth's EW Position: Q2 2026 in Review

DiNuzzo Private Wealth held its Edwards Lifesciences (EW) position steady in Q2 2026 at 41 shares worth $3.71K. The position accounts for ﹤0.01% of the portfolio, ranked #487.

DiNuzzo Private Wealth first reported a position in EW in Q4 2023 and has held it in 11 quarters since. 501 funds tracked by Wall St. Rank hold EW as of Q2 2026.

DiNuzzo Private Wealth held 41 shares of Edwards Lifesciences worth $3.71K as of Q2 2026.
DiNuzzo Private Wealth left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #487 holding.
DiNuzzo Private Wealth first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
501 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.